Alisa Lee Sherick, M.D.
An up-and-coming scientist from the University of Denver, Dr. Sherick is excited to conduct research on immunotherapy and leukemia. Her research is focused on how certain proteins shut down the body’s immune system and prevent it from attacking leukemia cells. Although early on in her career, she has already been published, and received numerous awards…
Austin Brown, Ph.D.
Cognitive deficits are a known effect of treatment for brain tumors in children. But not all children with brain tumors are affected by treatment equally. At Houston’s Baylor College of Medicine, Dr. Brown is focused on genetic markers, and their ability to predict which kids will be most adversely affected by treatment. Such findings could…
Theodore Nicolaides, M.D.
At University of California San Francisco, Dr. Nicolaides is developing treatments for children with glioma brain tumors. A new drug shown to be successful against this tumor has also shown to be very susceptible to resistance in certain patients. Understanding how that resistance develops can result in more effective drugs, and ultimately save lives.
Dr. Muller Fabbri, M.D., Ph.D.
Dr. Fabbri’s proposed research project focuses developing an effective but less toxic mechanism for treating Neuroblastoma. It is known that Neuroblastoma can be effectively treated with a type of cell in a person’s body called a Natural Killer Cell. However, Natural Killer Cell therapy is extremely toxic and often must be stopped before a patient…
Kevin Jones, M.D.
Dr. Kevin Jones is a researcher at Huntsman Cancer Institute (University of Utah) and an Associate Professor of Orthopaedics and Oncological Sciences and the University of Utah. He earned his M.D. from Johns Hopkins University. As an orthopaedic surgeon by training, he specializes in the care of pediatric patients with sarcoma. Dr. Jones is currently…
Prof. Dr. Franz Blaes
Dr. Blaes has been a Pablove Childhood Cancer Grant recipient from 2015-2017. He investigates a rare condition called opsoclonus-myoclonus-syndrome (OMS) and neuroblastoma-immune system interactions from his laboratory in Germany. His interest in the disease started during a post-doc in the Neuroscience group, Institute of Molecular Medicine in Oxford under the supervision of Angela Vincent and…
Ranjit S. Bindra, M.D., Ph.D.
Dr. Ranjit S. Bindra is an Assistant Professor of Therapeutic Radiology at Yale University. He earned his Ph.D. in experimental pathology and M.D. from Yale University School of Medicine. Dr. Bindra completed his residency in radiation oncology at Memorial Sloan-Kettering Cancer Center. He is a recipient of the Marie Curie Award. What is Dr. Bindra…
Gregory J. Aune, M.D., Ph.D.
Dr. Gregory John Aune is a Stephanie Edlund Distinguished Professor in Pediatric Cancer Research. He earned his Ph.D. and M.D. from University of Texas Health Science Center. Personal and professional experiences in pediatric cancer fueled his interest in childhood cancer. He is a long-term survivor of Hodgkin’s lymphoma. What is Dr. Aune currently researching? Pre-clinical…
- « Previous
- 1
- 2